Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence
出版年份 2020 全文链接
标题
Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence
作者
关键词
-
出版物
Advanced Science
Volume -, Issue -, Pages 2001447
出版商
Wiley
发表日期
2020-08-14
DOI
10.1002/advs.202001447
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Top 10 Challenges in Cancer Immunotherapy
- (2020) Priti S. Hegde et al. IMMUNITY
- Endogenous IL-33 and Its Autoamplification of IL-33/ST2 Pathway Play an Important Role in Asthma
- (2020) Jenna M. Magat et al. JOURNAL OF IMMUNOLOGY
- 3D Bioprinted In Vitro Metastatic Models via Reconstruction of Tumor Microenvironments
- (2019) Fanben Meng et al. ADVANCED MATERIALS
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Organ-on-a-Chip for Cancer and Immune Organs Modeling
- (2019) Wujin Sun et al. Advanced Healthcare Materials
- Embedding of Genes Using Cancer Gene Expression Data: Biological Relevance and Potential Application on Biomarker Discovery
- (2019) Chi Tung Choy et al. Frontiers in Genetics
- Turning the corner on therapeutic cancer vaccines
- (2019) Robert E. Hollingsworth et al. npj Vaccines
- Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapy
- (2019) Meike E. W. Logtenberg et al. NATURE MEDICINE
- Predicting Response to Cancer Immunotherapy using Non-invasive Radiomic Biomarkers
- (2019) S Trebeschi et al. ANNALS OF ONCOLOGY
- 3D-Bioprinted Mini-Brain: A Glioblastoma Model to Study Cellular Interactions and Therapeutics
- (2019) Marcel Alexander Heinrich et al. ADVANCED MATERIALS
- A Tumor‐on‐a‐Chip System with Bioprinted Blood and Lymphatic Vessel Pair
- (2019) Xia Cao et al. ADVANCED FUNCTIONAL MATERIALS
- Radiomics to predict response to immunotherapy, bridging the gap from proof of concept to clinical applicability?
- (2019) Eric Deutsch et al. ANNALS OF ONCOLOGY
- Multivascular networks and functional intravascular topologies within biocompatible hydrogels
- (2019) Bagrat Grigoryan et al. SCIENCE
- A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system
- (2019) Martin W. LaFleur et al. Nature Communications
- Application of Cancer Organoid Model for Drug Screening and Personalized Therapy
- (2019) Jumpei Kondo et al. Cells
- Cancer modeling meets human organoid technology
- (2019) David Tuveson et al. SCIENCE
- Organoids-on-a-chip
- (2019) Sunghee Estelle Park et al. SCIENCE
- Bioprinters for organs-on-chips
- (2019) Amir Miri et al. Biofabrication
- High-Throughput Microfluidic 3D Cytotoxicity Assay for Cancer Immunotherapy (CACI-IMPACT Platform)
- (2019) Dohyun Park et al. Frontiers in Immunology
- High-throughput peptide-MHC complex generation and kinetic screenings of TCRs with peptide-receptive HLA-A*02:01 molecules
- (2019) Andreas Moritz et al. Science Immunology
- Empty peptide-receptive MHC class I molecules for efficient detection of antigen-specific T cells
- (2019) Sunil Kumar Saini et al. Science Immunology
- Engineering patient-specific cancer immunotherapies
- (2019) Lindsay Scheetz et al. Nature Biomedical Engineering
- High-throughput genome-wide phenotypic screening via immunomagnetic cell sorting
- (2019) Barbara Mair et al. Nature Biomedical Engineering
- Predicting HLA class II antigen presentation through integrated deep learning
- (2019) Binbin Chen et al. NATURE BIOTECHNOLOGY
- Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes
- (2019) Julien Racle et al. NATURE BIOTECHNOLOGY
- Cancer Modeling‐on‐a‐Chip with Future Artificial Intelligence Integration
- (2019) Kirsten Lee Fetah et al. Small
- Model of Patient-Specific Immune-Enhanced Organoids for Immunotherapy Screening: Feasibility Study
- (2019) Konstantinos I. Votanopoulos et al. ANNALS OF SURGICAL ONCOLOGY
- A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity
- (2019) Fadi Jacob et al. CELL
- IMPRES does not reproducibly predict response to immune checkpoint blockade therapy in metastatic melanoma
- (2019) Jason A. Carter et al. NATURE MEDICINE
- Improved MHC II epitope prediction — a step towards personalized medicine
- (2019) Tamson V. Moore et al. Nature Reviews Clinical Oncology
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy
- (2019) Sarwish Rafiq et al. Nature Reviews Clinical Oncology
- 3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling
- (2018) Xuanyi Ma et al. ADVANCED DRUG DELIVERY REVIEWS
- Mechanisms of resistance to immune checkpoint inhibitors
- (2018) Russell W Jenkins et al. BRITISH JOURNAL OF CANCER
- A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
- (2018) Norman Sachs et al. CELL
- Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature
- (2018) Katharina Schwarze et al. GENETICS IN MEDICINE
- Improved methods for predicting peptide binding affinity to MHC class II molecules
- (2018) Kamilla Kjaergaard Jensen et al. IMMUNOLOGY
- Cancer immunotherapy μ-environment LabChip: taking advantage of optoelectronic tweezers
- (2018) Ling-Yi Ke et al. LAB ON A CHIP
- High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy
- (2018) Carsten Krieg et al. NATURE MEDICINE
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhancing responses to cancer immunotherapy
- (2018) Pia Kvistborg et al. SCIENCE
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
- (2018) Deng Pan et al. SCIENCE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Bioinks for 3D bioprinting: an overview
- (2018) P. Selcan Gungor-Ozkerim et al. Biomaterials Science
- Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids
- (2018) Krijn K. Dijkstra et al. CELL
- A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
- (2018) Roger Sun et al. LANCET ONCOLOGY
- Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
- (2018) Diana Miao et al. NATURE GENETICS
- Advances in organ-on-a-chip engineering
- (2018) Boyang Zhang et al. Nature Reviews Materials
- 73PGene embedding: A novel machine learning approach to identify gene candidates related to immunotherapy responsiveness
- (2018) C T Choy et al. ANNALS OF ONCOLOGY
- Organoid Modeling of the Tumor Immune Microenvironment
- (2018) James T. Neal et al. CELL
- Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function
- (2018) Eric Shifrut et al. CELL
- Towards the development of human immune-system-on-a-chip platforms
- (2018) Alessandro Polini et al. DRUG DISCOVERY TODAY
- Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer
- (2018) Qingzhu Jia et al. Nature Communications
- Engineering Precision Medicine
- (2018) Wujin Sun et al. Advanced Science
- Artificial intelligence in healthcare
- (2018) Kun-Hsing Yu et al. Nature Biomedical Engineering
- Artificial intelligence in medicine
- (2017) Pavel Hamet et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The benefits of immunotherapy combinations
- (2017) Charles Schmidt NATURE
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- Identification of essential genes for cancer immunotherapy
- (2017) Shashank J. Patel et al. NATURE
- In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
- (2017) Robert T. Manguso et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- CRISPR–Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome
- (2017) Tyler S Klann et al. NATURE BIOTECHNOLOGY
- Human primary liver cancer–derived organoid cultures for disease modeling and drug screening
- (2017) Laura Broutier et al. NATURE MEDICINE
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
- (2017) David P. Carbone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- The SysteMHC Atlas project
- (2017) Wenguang Shao et al. NUCLEIC ACIDS RESEARCH
- Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines
- (2017) Jason Lohmueller et al. PHARMACOLOGY & THERAPEUTICS
- Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors
- (2017) Yu Shrike Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
- (2017) Diego Chowell et al. SCIENCE
- Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape
- (2017) Abhishek D. Garg et al. TRENDS IN IMMUNOLOGY
- Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
- (2017) Russell W. Jenkins et al. Cancer Discovery
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Anti-tumor Activity of Toll-Like Receptor 7 Agonists
- (2017) Huju Chi et al. Frontiers in Pharmacology
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Rapid Continuous Multimaterial Extrusion Bioprinting
- (2016) Wanjun Liu et al. ADVANCED MATERIALS
- 3D Bioprinting for Tissue and Organ Fabrication
- (2016) Yu Shrike Zhang et al. ANNALS OF BIOMEDICAL ENGINEERING
- Direct 3D bioprinting of perfusable vascular constructs using a blend bioink
- (2016) Weitao Jia et al. BIOMATERIALS
- Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
- (2016) Jiangtao Ren et al. CLINICAL CANCER RESEARCH
- Microfluidic models for adoptive cell-mediated cancer immunotherapies
- (2016) Giulia Adriani et al. DRUG DISCOVERY TODAY
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Designer vaccine nanodiscs for personalized cancer immunotherapy
- (2016) Rui Kuai et al. NATURE MATERIALS
- The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
- (2016) Danny N. Khalil et al. Nature Reviews Clinical Oncology
- Combine and conquer: challenges for targeted therapy combinations in early phase trials
- (2016) Juanita S. Lopez et al. Nature Reviews Clinical Oncology
- Phase II and phase III failures: 2013–2015
- (2016) Richard K. Harrison NATURE REVIEWS DRUG DISCOVERY
- Coming of age: ten years of next-generation sequencing technologies
- (2016) Sara Goodwin et al. NATURE REVIEWS GENETICS
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
- (2016) E. Stronen et al. SCIENCE
- The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas
- (2016) D. F. Quail et al. SCIENCE
- Bioprinting towards Physiologically Relevant Tissue Models for Pharmaceutics
- (2016) Weijie Peng et al. TRENDS IN BIOTECHNOLOGY
- Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium
- (2016) Eileen S. Kim et al. Journal of Immunology Research
- Bioprinting the Cancer Microenvironment
- (2016) Yu Shrike Zhang et al. ACS Biomaterials-Science & Engineering
- Role of IL-2 in cancer immunotherapy
- (2016) Tao Jiang et al. OncoImmunology
- Bioprinting the Cancer Microenvironment
- (2016) Yu Shrike Zhang et al. ACS Biomaterials Science & Engineering
- Rapid 3D Extrusion of Synthetic Tumor Microenvironments
- (2015) Joshua M. Grolman et al. ADVANCED MATERIALS
- Microfluidic Bioprinting of Heterogeneous 3D Tissue Constructs Using Low-Viscosity Bioink
- (2015) Cristina Colosi et al. ADVANCED MATERIALS
- From big data analysis to personalized medicine for all: challenges and opportunities
- (2015) Akram Alyass et al. BMC Medical Genomics
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
- (2015) Marc van de Wetering et al. CELL
- Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance
- (2015) Willy Hugo et al. CELL
- A Genome-wide CRISPR Screen in Primary Immune Cells to Dissect Regulatory Networks
- (2015) Oren Parnas et al. CELL
- Organoid Models of Human and Mouse Ductal Pancreatic Cancer
- (2015) Sylvia F. Boj et al. CELL
- Cancer immunotherapy: harnessing the immune system to battle cancer
- (2015) Yiping Yang JOURNAL OF CLINICAL INVESTIGATION
- Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
- (2015) Silvana Konermann et al. NATURE
- Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids
- (2015) Mami Matano et al. NATURE MEDICINE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2015) Timothy A. Chan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases
- (2015) Fleur Weeber et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Immunogenicity of somatic mutations in human gastrointestinal cancers
- (2015) E. Tran et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
- (2015) Juan Fu et al. Science Translational Medicine
- Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells
- (2015) M. J. Frigault et al. Cancer Immunology Research
- A new age in functional genomics using CRISPR/Cas9 in arrayed library screening
- (2015) Alexander Agrotis et al. Frontiers in Genetics
- Automated, Miniaturized, and Integrated Quality Control-on-Chip (QC-on-a-Chip) for Cell-Based Cancer Therapy Applications
- (2015) David Wartmann et al. Frontiers in Materials
- Organoid Cultures Derived from Patients with Advanced Prostate Cancer
- (2014) Dong Gao et al. CELL
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- Hydrogel bioprinted microchannel networks for vascularization of tissue engineering constructs
- (2014) Luiz E. Bertassoni et al. LAB ON A CHIP
- Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
- (2014) Mahesh Yadav et al. NATURE
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- Microfluidic organs-on-chips
- (2014) Sangeeta N Bhatia et al. NATURE BIOTECHNOLOGY
- Linking T-cell receptor sequence to functional phenotype at the single-cell level
- (2014) Arnold Han et al. NATURE BIOTECHNOLOGY
- Phenotypic screening in cancer drug discovery — past, present and future
- (2014) John G. Moffat et al. NATURE REVIEWS DRUG DISCOVERY
- Three-dimensional printing of Hela cells for cervical tumor modelin vitro
- (2014) Yu Zhao et al. Biofabrication
- 3D printing of biomimetic microstructures for cancer cell migration
- (2013) Tina Qing Huang et al. BIOMEDICAL MICRODEVICES
- Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients
- (2013) Gerald Schwank et al. Cell Stem Cell
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- High-throughput identification of antigen-specific TCRs by TCR gene capture
- (2013) Carsten Linnemann et al. NATURE MEDICINE
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Combination immunotherapy approaches
- (2012) C. G. Drake ANNALS OF ONCOLOGY
- RNA-guided genetic silencing systems in bacteria and archaea
- (2012) Blake Wiedenheft et al. NATURE
- Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues
- (2012) Jordan S. Miller et al. NATURE MATERIALS
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- Oncolytic Virus-initiated Protective Immunity Against Prostate Cancer
- (2011) Shashi A Gujar et al. MOLECULAR THERAPY
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells
- (2011) Chao Ma et al. NATURE MEDICINE
- Impact of high-throughput screening in biomedical research
- (2011) Ricardo Macarron et al. NATURE REVIEWS DRUG DISCOVERY
- Cytokines in Cancer Immunotherapy
- (2011) Sylvia Lee et al. Cancers
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune Therapy Steps Up the Attack
- (2010) J. Couzin-Frankel SCIENCE
- ChIP–seq: advantages and challenges of a maturing technology
- (2009) Peter J. Park NATURE REVIEWS GENETICS
- T cell heterogeneity: firmly fixed, predominantly plastic or merely malleable?
- (2008) John J O'Shea et al. NATURE IMMUNOLOGY
- RNA-Seq: a revolutionary tool for transcriptomics
- (2008) Zhong Wang et al. NATURE REVIEWS GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started